She is the scientific representative of the LUMC in the TREAT-NMD governing board. During her PhD research she was involved in the development of therapeutic antisense-mediated exon skipping for DMD. She successfully defended her thesis titled “Development of an antisense-mediated exon skipping therapy for Duchenne muscular Dystrophy – Making sense out of nonsense” in February 2005 and now continues to work on the further optimization of the exon skipping therapy.